lorazepam has been researched along with 2019 Novel Coronavirus Disease in 15 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Status Epilepticus is the most common non-traumatic neurologic emergency in childhood." | 5.72 | Resolution of status epilepticus after ketamine administration. ( Hakmeh, W; Howing, CE; Razi, F, 2022) |
| "Lorazepam was successfully used, along with electroconvulsive therapy, antipsychotics, and other treatments." | 3.01 | COVID-19 and catatonia: Prevalence, challenges, pathophysiology, and treatment. ( Koola, MM; Mohammadi, T; Oh, J; Pradhan, BK; Sahota, PC, 2023) |
| "Status Epilepticus is the most common non-traumatic neurologic emergency in childhood." | 1.72 | Resolution of status epilepticus after ketamine administration. ( Hakmeh, W; Howing, CE; Razi, F, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 15 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Avila, C | 1 |
| Rauseo Lopez, LF | 1 |
| Mandelia, Y | 1 |
| Howing, CE | 1 |
| Razi, F | 1 |
| Hakmeh, W | 1 |
| Shudofsky, KN | 1 |
| Janssen, PKC | 1 |
| Foudraine, N | 1 |
| le Noble, JLML | 1 |
| Adhikari, S | 1 |
| Kumar, R | 1 |
| Driver, EM | 1 |
| Bowes, DA | 1 |
| Ng, KT | 1 |
| Sosa-Hernandez, JE | 1 |
| Oyervides-Muñoz, MA | 1 |
| Melchor-Martínez, EM | 1 |
| Martínez-Ruiz, M | 1 |
| Coronado-Apodaca, KG | 1 |
| Smith, T | 1 |
| Bhatnagar, A | 1 |
| Piper, BJ | 1 |
| McCall, KL | 1 |
| Parra-Saldivar, R | 1 |
| Barron, LP | 1 |
| Halden, RU | 1 |
| Wiemann, B | 3 |
| Mitchell, J | 3 |
| Sarangarm, P | 3 |
| Miskimins, R | 3 |
| Oh, J | 1 |
| Sahota, PC | 1 |
| Mohammadi, T | 1 |
| Pradhan, BK | 1 |
| Koola, MM | 1 |
| Pérez, T | 1 |
| Pardo, MC | 1 |
| Cabellos, Y | 1 |
| Peressini, M | 1 |
| Ureña-Vacas, I | 1 |
| Serrano, DR | 1 |
| González-Burgos, E | 1 |
| Wang, K | 1 |
| Zhang, Z | 1 |
| Yu, M | 1 |
| Tao, Y | 1 |
| Xie, M | 1 |
| Antunes, B | 1 |
| Bowers, B | 1 |
| Winterburn, I | 1 |
| Kelly, MP | 1 |
| Brodrick, R | 1 |
| Pollock, K | 1 |
| Majumder, M | 1 |
| Spathis, A | 1 |
| Lawrie, I | 1 |
| George, R | 1 |
| Ryan, R | 1 |
| Barclay, S | 1 |
| Uvais, NA | 1 |
| Gouse, BM | 1 |
| Spears, WE | 1 |
| Nieves Archibald, A | 1 |
| Montalvo, C | 1 |
| Jaworowski, S | 1 |
| Weiser, M | 1 |
| Gropp, C | 1 |
| Malka, M | 1 |
| Haddad, PM | 1 |
| Al Abdulla, M | 1 |
| Latoo, J | 1 |
| Iqbal, Y | 1 |
| Marouda, K | 1 |
| Mantonakis, L | 1 |
| Kollias, K | 1 |
| Reinfeld, S | 1 |
| Yacoub, A | 1 |
1 review available for lorazepam and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
COVID-19 and catatonia: Prevalence, challenges, pathophysiology, and treatment.
Topics: Catatonia; COVID-19; Electroconvulsive Therapy; Humans; Lorazepam; Mental Disorders; Prevalence | 2023 |
14 other studies available for lorazepam and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Acute COVID-19 Infection Associated With Necrotizing Disseminated Acute Leukoencephalopathy and Brain Microhemorrhages in a Pediatric Patient.
Topics: Adolescent; Anticonvulsants; COVID-19; COVID-19 Drug Treatment; Female; Humans; Immunoglobulins, Int | 2021 |
Resolution of status epilepticus after ketamine administration.
Topics: Aftercare; Anticonvulsants; COVID-19; Female; Humans; Infant; Ketamine; Levetiracetam; Lorazepam; Pa | 2022 |
Clearance of Lormetazepam, Midazolam, and Their Conjugated Metabolites by Continuous Venovenous Hemofiltration During Prolonged Sedation in Critically Ill Patients With COVID-19-Associated Acute Respiratory Distress Syndrome.
Topics: Aged; Continuous Renal Replacement Therapy; COVID-19; COVID-19 Drug Treatment; Critical Illness; Dee | 2022 |
Occurrence of Z-drugs, benzodiazepines, and ketamine in wastewater in the United States and Mexico during the Covid-19 pandemic.
Topics: Alprazolam; Benzodiazepines; Clonazepam; COVID-19; Diazepam; Humans; Ketamine; Lorazepam; Mexico; No | 2023 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Mental health and drug use in college students: Should we take action?
Topics: Anxiety; COVID-19; Depression; Humans; Lorazepam; Mental Health; Students; Substance-Related Disorde | 2023 |
15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study.
Topics: Age Factors; Aged; Betacoronavirus; China; Coronavirus Infections; COVID-19; Critical Illness; Drug | 2020 |
Anticipatory prescribing in community end-of-life care in the UK and Ireland during the COVID-19 pandemic: online survey.
Topics: Administration, Buccal; Administration, Sublingual; Analgesics, Non-Narcotic; Analgesics, Opioid; Be | 2020 |
Psychological Impact of the COVID-19 Pandemic Among the Elderly: A Case Series From India.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents; Betacoronavirus; Ci | 2020 |
Catatonia in a hospitalized patient with COVID-19 and proposed immune-mediated mechanism.
Topics: Aged; Atrial Fibrillation; Basal Ganglia; Betacoronavirus; C-Reactive Protein; Catatonia; Coronaviru | 2020 |
Three Cases of COVID-19-related First Onset Brief Reactive Psychosis.
Topics: Adult; Antipsychotic Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Delusions; Haloperid | 2020 |
Brief psychotic disorder associated with quarantine and mild COVID-19.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; COVID-19; Humans; Lorazepam; Ma | 2020 |
Brief psychotic disorder with delusion content related to the COVID-19 outbreak.
Topics: Adult; Aggression; Anti-Anxiety Agents; Antipsychotic Agents; COVID-19; Delusions; Humans; Involunta | 2021 |
A Case of Delirious Mania Induced by COVID-19 Treated With Electroconvulsive Therapy.
Topics: COVID-19; Delirium; Electroconvulsive Therapy; Humans; Lorazepam; Male; Mania; Mental Status and Dem | 2021 |